News

SMS Pharmaceuticals announced that the 38th Annual General Meeting(AGM) of the company will be held on 23 September 2026.

Net profit of SMS Pharmaceuticals rose 2.05% to Rs 20.91 crore in the quarter ended June 2026 as against Rs 20.49 crore during the previous quarter ended June 2025. Sales rose 5.56% to Rs 206.96 crore in the quarter ended June 2026 as against Rs 196.05 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales206.96196.05 6 OPM %19.7920.08 - PBDT37.2034.12 9 PBT27.2124.37 12 NP20.9120.49 2 Powered by Capital Market - Live News

SMS Pharmaceuticals has revised the meeting of the Board of Directors which was scheduled to be held on 1 August 2026. The meeting will now be held on 31 July 2026.

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 August 2026.

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 0.4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.